Article
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Proceedings of the National Academy of Sciences of the United States of America - 29 Apr 2014
Veiseh Mandana, Kwon Daniel H, Borowsky Alexander D, Tolg Cornelia, Leong Hon S, Lewis John D, Turley Eva A, Bissell Mina J
Abstract excerpt
Tumor heterogeneity confounds cancer diagnosis and the outcome of therapy, necessitating analysis of tumor cell subsets within the tumor mass. Elevated expression of hyaluronan (HA) and HA receptors, receptor for HA-mediated motility (RHAMM)/HA-mediated motility receptor and cluster designation 44 (CD44), in breast tumors correlates with poor outcome. We hypothesized that a probe for detecting HA-HA receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
